The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nabulsi Azmi since 2020.
This trader's CIK number is 1791412.
At the time of last reporting, Nabulsi Azmi was the Chief Operating Officer of Phathom Pharmaceuticals, Inc.. (stock ticker symbol PHAT).
Also see all insider trading activities at Phathom Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | PHAT | 0 | $0 | 12,019 | $136,703 | 0 | $0 |
| 2023 | PHAT | 10,000 | $82,600 | 0 | $0 | 0 | $0 |
| 2022 | PHAT | 20,000 | $163,280 | 0 | $0 | 0 | $0 |
| 2021 | PHAT | 0 | $0 | 58,000 | $2,266,635 | 0 | $0 |
| 2020 | PHAT | 0 | $0 | 29,000 | $1,184,536 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-19 | PHAT | Sale | 1,118 | 8.00 | 8,944 |
| 2024-07-15 | PHAT | Sale | 10,901 | 11.72 | 127,759 |
| 2023-04-11 | PHAT | Buy | 10,000 | 8.26 | 82,600 |
| 2022-05-16 | PHAT | Buy | 20,000 | 8.16 | 163,280 |
| 2021-04-01 | PHAT | Sale | 5,147 | 37.71 | 194,088 |
| 2021-04-05 | PHAT | Sale | 9,353 | 36.38 | 340,271 |
| 2021-03-01 | PHAT | Sale | 5,373 | 45.91 | 246,685 |
| 2021-03-02 | PHAT | Sale | 9,127 | 45.78 | 417,806 |
| 2021-02-01 | PHAT | Sale | 5,416 | 38.09 | 206,284 |
| 2021-02-02 | PHAT | Sale | 9,084 | 40.84 | 370,954 |
| 2020-01-04 | PHAT | Sale | 12,646 | 33.84 | 427,940 |
| 2020-01-05 | PHAT | Sale | 1,854 | 33.77 | 62,607 |
| 2020-12-01 | PHAT | Sale | 7,198 | 44.41 | 319,663 |
| 2020-12-02 | PHAT | Sale | 7,302 | 45.31 | 330,853 |
| 2020-11-02 | PHAT | Sale | 14,500 | 36.83 | 534,020 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nabulsi Azmi (Chief Operating Officer of Phathom Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.